Jessica serves as an Associate Director for Patient Recruitment Programs at Quintiles. She has worked in clinical research for over 12 years. Throughout her career in clinical research, Ms. Perry held roles on clinical study teams as CRA, Clinical Trial Leader and Clinical CRA manager. She joined the Patient Recruitment Programs team to support development of strategies using her in-depth clinical study experience with particular focus on Rare & Orphan diseases. Ms. Perry also sits on the Quintiles Rare & Orphan Disease Platform team.
Ms. Perry has worked on phase II, III, & IV clinical trials and this experience spans the execution of clinical trials, from study start-up to project close-out and archival. Ms. Perry’s therapeutic experience includes cardiovascular therapies, multiple sclerosis, depression, women’s health, pediatric medicine, and infectious disease. She has supported multiple rare disease indications including Hypophosphatasia (HPP), paroxysmal nocturnal hemoglobinuria (PNH), Fabry Disease and Molybdenum cofactor deficiency (MoCD) as well as development of overall rare disease recruitment practices. Ms. Perry also has expert working knowledge of FDA regulations, ICH guidelines, Good Clinical Practices and Standard Operating Procedures.